IKT:US
$1.80
12.50%

Inhibikase Therapeutics Inc.
Key Data

Last updated: Aug 6, 2025, 6:51 AM ET

Price Metrics  

  • Open
    1.61
  • Close
    1.80
  • Prev. Close
    1.60
  • Day High/Low
    1.83/1.57
  • 52 Week High/Low
    4.20/1.12
  • Alpha
    -0.032
  • Beta
    0.909
  • VWAP
    1.753

Moving Averages  

  • 21 Day Moving Average
    1.821
  • 50 Day Moving Average
    1.849
  • 200 Day Moving Average
    2.315

Valuation Metrics  

  • Market Cap (All Classes)
    133,814,772.00
  • Market Cap
    133,814,772.00
  • EPS (TTM)
  • P/E Ratio (TTM)
  • P/B Ratio
    1.39
  • P/CF Ratio
    -7.30
  • D/E Ratio
  • Return on Equity
    -79.02%
  • Return on Assets
    -69.39%

Share Statistics  

  • Total Shares (All Classes)
    74,341,540.00
  • Listed Shares Outstanding
    74,341,540.00
  • Escrow Shares
  • Volume
    145,478.00
  • 10 Day Avg Vol.
    112,370.00
  • 20 Day Avg Vol.
    122,309.00
  • 30 Day Avg Vol.
    374,926.00
  • 50 Day Avg Vol.
    283,230.00

Dividends  

  • Dividend
  • Dividend Frequency
  • Dividend Yield (Ann)
  • Ex-Date
  • Payable date
  • Dividend Growth (3 Year)
  • Dividend Growth (5 Year)

Short Interest (as of Aug 6, 2025)  

  • Short Interest as % of Float
    -%
  • Short Interest Days to Cover
    -
Want more in-depth company research in real-time?
Learn more about TMX Powerstream today.